<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="121139">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01525732</url>
  </required_header>
  <id_info>
    <org_study_id>CRE-2010_430</org_study_id>
    <nct_id>NCT01525732</nct_id>
  </id_info>
  <brief_title>Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Esophageal Motility Disorders</brief_title>
  <acronym>POEM</acronym>
  <official_title>Prospective Study on the Feasibility and Effectiveness of Per-Oral Endoscopic Myotomy (P.O.E.M.) for Treatment of Primary Esophageal Motility Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <brief_summary>
    <textblock>
      Spastic esophageal motility disorders induced significant symptoms including dysphagia,
      retrosternal pain and regurgitation. Per oral endoscopic myotomy (P.O.E.M.) is a novel
      approach to perform myotomy through the esophagus with long submucosal tunnel. This study
      aimed to investigate the feasibility and safety of P.O.E.M. and translate the techniques
      from animal study to clinical practice in human.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dysphagia score before and after P.O.E.M.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Eckardt score before and after P.O.E.M.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative complication</measure>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Achalasia</condition>
  <condition>Hypertensive LES</condition>
  <arm_group>
    <arm_group_label>POEM</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Per Oral Endoscopic Myotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Per Oral Endoscopic Myotomy</intervention_name>
    <arm_group_label>POEM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with age ranged 18 to 80 who had primary esophageal motility disorders
             will be recruited. The primary motility disorders included: Achalasia, hypertensive
             LES, Nutcracker esophagus and Diffuse esophageal spasm.

        Exclusion Criteria:

          -  Patients will be excluded from this study with the followings -

               1. Pregnancy

               2. Informed consent not available

               3. Previous history of esophagectomy or mediastinal surgery

               4. Previous history of endoscopic resection for early esophageal cancers, including
                  endoscopic mucosal resection and endoscopic submucosal dissection

               5. End-stage Achalasia with dilated esophagus more than 6cm on Barium swallow
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Philip WY Chiu, MD</last_name>
    <phone>85226322627</phone>
    <email>philipchiu@surgery.cuhk.edu.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip WY Chiu, MD</last_name>
      <phone>85226322627</phone>
      <email>philipchiu@surgery.cuhk.edu.hk</email>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <lastchanged_date>September 5, 2014</lastchanged_date>
  <firstreceived_date>February 1, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Philip Wai Yan Chiu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Achalasia, Hypertensive LES</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Esophageal Achalasia</mesh_term>
    <mesh_term>Esophageal Motility Disorders</mesh_term>
    <mesh_term>Esophageal Spasm, Diffuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
